Aignostics
PrivateLast Round
Series B
Oct 29, 2024
Total Funding Raised
$53.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aignostics is a healthcare technology company that provides an artificial intelligence-driven image analysis platform to enhance precision medicine by providing explainable diagnostic insights for cancer and complex disease diagnosis and treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aignostics Comparables
Compare Aignostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nucleai | 87% | |
| AIRA Matrix | 83% | |
| Tempus | 83% | |
Aignostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 29, 2024 | ||||
| Series A | Sep 15, 2022 | ||||
| Seed | Aug 28, 2020 | ||||
| Accelerator | Jan 1, 2018 |
Aignostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IBB Ventures | Series B, Series A, Seed |
| Athos KG | Series B |
| Ascenion | Series B, Series A |
| Boehringer Ingelheim Venture Fund | Series B, Series A, Seed |
| Wellington Partners | Series B, Series A |
| Future Capital AG | Seed |
| BIH Digital Health Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 108% MoM, reaching 12.5K.
- Jun 5, 2026
Company is a spin-off from the Charité university hospital.
Aignostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aignostics's valuation, stock price, and market status.